Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
With the exception of perhaps energy companies, it would be worrying if I company didn’t strike a cautious tone when presenting its results. Beximco have done this as well as turning in a reasonable performance.
they had export decline but a very nice increase in sales overall,which is what counts...they have overcome strong headwinds encountered by most companies extremely well.....I am very happy with the company....they really deserve to be much higher......A company consistently increasing sales...yer after year....great management....at a stupidly low PE
i guess export decline is loss of covid sales?
A pe of 6.5.....on a growth trajectory.....very very cheap....very cheap...
Headwinds there may be, but EPS at 10p is not to be sneered at, nor Dividend at 3.5p!
Export decline is very disappointing ; you’d think cheap generics would do well in a cost of living squeeze. Must be more there to explain the situation.
results pretty lacklustre
"headwinds" in first quarter of 2022/3 as well
probably on forward p/e close to 15 now which seems ok given longer term prospects...but pretty high given how weak wider market is and country risks
the discount is something like (160-70)/160...which is high by historic standards
===> curate's egg lol
my guess is we may bottom just below 50p
Just noticed the 3.5 takka dividend declaration. I think that about 4.3% at the current ask price.
Steady away.
Yes it’s tricky getting consistent estimates! Cheers though.
https://www.amarstock.com/stock/BXPHARMA
This site puts it at 83 which could well be around 67 in Sterling. Im never convinced these sites get the maths correct though given the number of GDRs.
Yes we trade below on the LSE by a fair bit. I was trying to find out the NAV. I think I read 67p somewhere but I’m not 100%! sure.
Look up Dhaka stock exchange, then look up Beximco Pharmaceuticals. First you will see that the share price there is much higher, much higher than here, but the shares here don’t have voting rights - much do I care about that. Dividends the same!
Does anybody have a NAV value for Beximco? Cheers
Unusually large trades booked.
I can’t see anything company specific. The domestic exchange took a bit of a battering yesterday it looks like but still trading at 146p equivalent.
I think the drop here is simply linked to a few wanting cash out of the market generally and the poor liquidity on this stock magnifies the issue.
So nothing company specific, which is good but possible headwinds.
EM type concerns spooked a few. There was a country-wide blackout in Bangladesh 2 days ago. Power cuts becoming more common. Plus there’s been some reports about the central bank getting low on foreign ccy reserves trying to defend the ccy against the strong USD.
What caused the drop here to £0.67? I can’t see any rns but I am aware that we are due an update from BXP early next month.
Can anyone tell me why some brokers say you can't hold BXP in an ISA? I'm with x-o (JIM) and hold BXP there but wondered if this will be stopped at some point? Is this what has caused the drop in BXP SP? I'd be grateful for any info/advice around this.
very rarely been at this discount (dyor)
I think the price has drifted with general market sentiment rather than anything specific at BXP.
The market in Bangladesh seemed to have a great session yesterday including an 8% rise for us. Domestic share price now 168p equivalent which has left us trailing at around 44%. At our usual 60% equivalence we would be a shiny pound.
At present, the dollar is very strong. Will this have an effect on Beximco’s earnings or not? I’m just wondering why this share has drifted down from about £1.30 ish on no bad company news.
Domestic price gentle rising and the exchange rate has moved in our favour. Domestic price now around 150p so we have sunk to just over 50%. I think we might see a little rise here soon, 90p would be 60%.
BXP's share price in Dhaka up 2.7%. today, a nice rise in unsettled markets! Pharmaceuticals like BXP should survive looming recessions in good shape, indeed grow.